跳至主要内容
临床试验/2024-511008-17-00
2024-511008-17-00招募中4 期

(LAX) A Randomized, open label, Non-inferiority trial on the efficacy of Lacosamide versus Duloxetine in Patients with Chemotherapy-induced Polyneuropathy - A strategy trial

Leids Universitair Medisch Centrum (LUMC)1 个研究点 分布在 1 个国家目标入组 110 人开始时间: 2024年7月29日最近更新:

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
110
试验地点
1
主要终点
Pain intensity score during the last 4 weeks of treatment

研究概览

简要总结

To explore the analgesic effect of lacosamide compared to duloxetine in patients with painful chemotherapy-induced polyneuropathy

入排标准

年龄范围
18 years 至 65+ years(18-64 Years, 65+ Years)
接受健康志愿者

入选标准

  • Age> 18 years
  • Able to give oral and written informed consent
  • Indications of small- or large fiber neuropathy with quantitative sensory testing (compared to healthy population).
  • Pain score of 4 or higher
  • Chemotherapy with taxanes, platinums, vicalkiniods or bortezomib in the past
  • Presence of symptoms of neuropathic pain at least 3 months after the last chemotherapy

排除标准

  • Allergy to the study medication
  • Kidney dysfunction (GFR < 30 mL/min)
  • Severe heart failure (e.g. as a result of infarction or a structural heart defect)
  • Heart Rhythm Disorders (including 2nd or 3rd degree atrioventricular (AV) block and sodium channelopathies.
  • Systolic blood pressure above 180mm Hg with current antihypertensive medications (according to screening measurement)
  • Any condition that by the judgement of the investigator might interfere with the investigation
  • History of illicit drug or alcohol abuse
  • History of psychosis
  • Pregnancy or lactation
  • Use of anti-epileptic or anti-depressant medication (in particular MAO inhibitors)
  • Use of CYP1a2 inhibitors (e.g. fluvoxamine, fluocinolone, cimetidine)
  • Concomitant neuropathy other than chemotherapy-induced
  • Moderate and severe liver enzyme abnormalities

结局指标

主要结局

Pain intensity score during the last 4 weeks of treatment

Pain intensity score during the last 4 weeks of treatment

次要结局

  • Patient satisfaction of treatment
  • Side effect profile

研究者

发起方
Leids Universitair Medisch Centrum (LUMC)
申办方类型
Hospital/Clinic/Other health care facility
责任方
Principal Investigator
主要研究者

Marieke Niesters

Scientific

Leids Universitair Medisch Centrum (LUMC)

研究点 (1)

Loading locations...

相似试验